Showing results (1801-1810 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|August 14, 2024
More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren's diseaseGeertje Elizabeth Legger, Uzma Nakshbandi, Martha S van Ginkel, et al.
RMD Open|August 20, 2024
Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based studyMajd Bairkdar, Zihan Dong, Pontus Andell, et al.
RMD Open|September 5, 2024
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trialsKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
RMD Open|June 28, 2024
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA studyPeter C Taylor, Georg Schett, Tom Wj Huizinga, et al.
RMD Open|June 17, 2024
Synthesis of guidance available for assessing methodological quality and grading of evidence from qualitative research to inform clinical recommendations: a systematic literature reviewMandeep Sekhon, Annette de Thurah, George E Fragoulis, et al.
RMD Open|June 17, 2024
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance databaseRyoko Sakai, Eiichi Tanaka, Eisuke Inoue, et al.
RMD Open|June 17, 2024
Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohortsKeigo Hayashi, Gregory C McDermott, Pierre-Antoine Juge, et al.
RMD Open|June 13, 2024
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosusYurie Satoh-Kanda, Shingo Nakayamada, Satoshi Kubo, et al.
RMD Open|June 11, 2024
Two-year clinical follow-up enhances the diagnosis of early-stage hip osteoarthritis: data from check cohortJos Runhaar, Ömer Özbulut, Margreet Kloppenburg, et al.
RMD Open|June 8, 2024
International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globeMarco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, et al.
Pageof 197